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Summary Intra- and extracellular pH (pHi and pH,) were measured simultaneously by "P magnetic
resonance spectroscopy (MRS) in CaNT tumours before and after blood flow modification. Before
modification, pHi was 7.1 ± 0.09 (n = l1) and pHe [measured with an MRS-visible extracellular marker,
3-aminopropyl phosphonate (3-APP)] was 6.7 ± 0.05 (n = 8). Chemical shift imaging and localised MRS
experiments showed that the 3-APP signal was only from the tumour, not surrounding tissue. After
modification by vascular occlusion, independent of whether tumours were maintained at room temperature
(22-24°C) or kept warm (33-35°C), there was a decrease in pHi and pHe with pHi decreasing to a greater
extent. Qualitatively similar results were found using flavone acetic acid (FAA) as a blood flow modifier; only
four out of nine tumours responded to FAA. Concomitant with the reduction of the pH gradient after
modification was a decrease in the phosphorylation state of the adenine nucleotides measured either as ATP/Pi
by MRS or [ATP]/[ADP][Pj] in tumour extracts. These results indicate that the intracellular uptake of
chemotherapeutic drugs which are dependent on the transmembrane pH gradient will not be enhanced in cells
made ischaemic as a result of vascular shutdown.
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In the quest for new anti-cancer strategies for solid tumours
many approaches have been tried using pH (for review see
Wike-Hooley et al., 1984). These include various strategies
for altering pH: lowering the pH to make the tumour cell
more sensitive to a particular treatment modality, e.g. hyper-
thermia (Hiraoka and Hahn, 1989), or accentuating pH
gradients (ApH) between intra- and extracellular compart-
ments (Gerweck et al., 1991). To achieve the latter various
methods have been tried: inducing hyperglycaemia to inc-
rease lactic acid production and thus lower pH (Evelhoch et
al., 1984; Hwang et al., 1991; Jahde et al., 1992); inhibiting
the Na+/H+ exchanger with amiloride and its analogues
(Newell et al., 1992; Maidorn et al., 1993) and using com-
pounds [e.g. hydralazine, flavone acetic acid FAA] that
specifically reduce blood flow to tumours (Vorhees and
Babbs, 1982; Evelhoch et al., 1988; Parkins et al., 1994a) to
make the tumours more anoxic and therefore more acid. By
using these various strategies, it is hoped that the pH
differences can be exploited either by activating cytotoxic
agents selectively within tumours (Tannock and Rotin, 1989;
Newell et al., 1992) or by altering the distribution of drugs
that are weak acids or bases (Gerweck et al., 1991) in such a
way that they will be taken up more effectively by the
tumour than by the normal surrounding tissue. Several drugs
(e.g. mitomycin C, chlorambucil) have been shown to have
increased cytotoxicity in vitro in isolated cell experiments at
low extracellular pH (pH.) (Maidorn et al., 1993; Parkins et
al., 1993, 1994b). These drugs have also caused growth delay
in vivo in some tumour types (Newell et al., 1992; Parkins et
al., 1994b).
Following the classical experiments of Warburg in the
1920s, for many years tumours were thought to be acidic, but
it is now generally accepted (Vaupel et al., 1989; Griffiths,
1991) that tumour intracellular pH (pHi) is close to neut-
rality. 31p magnetic resonance spectroscopy (MRS) has
confirmed non-invasively that pHi in both human and animal
tumours is on the alkaline side of neutrality: pH 7.1-7.2
(Vaupel et al., 1989; Griffiths, 1991; Evelhoch, 1992; Negen-
dank, 1992) which is similar to that in most normal tissues.
Confirmation that the measurement of tumour pH by MRS
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is largely representative of pHi has been made in animal
tumours (Stubbs et al., 1992). It is now possible, with the aid
of an MRS-visible extracellular marker 3-aminopropyl phos-
phonate (3-APP) (Gillies et al., 1994) to measure pHe in vivo.
3-APP is not toxic to C6 glioma or Ehrlich ascites tumour
cells at concentrations up to 20mM (Gillies et al., 1994).
Thus it may be used for monitoring the course ofthe ApH of
solid tumours in vivo after therapy. Since in vitro and in vivo
experiments with CaNT tumour cells have shown dependence
of drug cytotoxicity on pH,, enhancement of cell kill at low
pH, and dependence of ischaemia-induced cell death on
temperature (Parkins et al., 1993, 1994a,b), the purpose of
the work reported here was to monitor pHi and pH. simul-
taneously by 31p MRS in CaNT murine tumours before and
after blood flow modification. The ApH was monitored in
three cohorts of mice, before and up to 2 h after total
vascular occlusion. The core temperature was maintained at
preocclusion values (33-35'C) or allowed to cool naturally
to room temperature (22-24'C) after cessation ofblood flow.
The results showed that the ApH decreased after vascular
occlusion and that there was a decrease in both pHi and pH,
after treatment with FAA in the four out of nine tumours
that responded to FAA.
Materials and methods
Tumours
Moderately differentiated murine adenocarcinoma NT (CaNT)
tumours were grown subcutaneously on the lower dorsum of
syngeneic CBA/Gy fTO mice and examined when they were
about 1Omm in diameter. The mice were divided into two
groups for MRS measurements and freeze clamping. The
mice were anaesthetised intraperitoneally (i.p.) with ketamine
(50 mgkg-') (Parke-Davis, UK) and diazepam (25 mgkg-')
(Phoenix Pharmaceuticals, UK) to avoid motion artefacts
during MRS measurements.
Injection of3-APP and FAA
The mice were injected with 0.3 ml of 128 mgml-I of 3-APP
(Sigma, UK) i.p. (12-l5iLmolg' body weight), 30min
before the spectra were collected. In the studies with FAAIntra- and extracellular pH measured by 31p MRS
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(provided by Lipha Pharmaceutical, Lyon, France), this was
also administered i.p. (200 mgkg-') but 10-15 min after the
3-APP.
Total vascular occlusion
Because remotely controlled non-magnetic occlusion devices
are difficult to make, vascular occlusion was achieved by an
intravenous (i.v.) injection of a lethal dose of euthatal via an
in-dwelling tail vein cannula with a line for remote injection
inserted before the mouse was placed in the magnet.
MRS measurements
MRS measurements were made on a Sisco 200-330 at 4.7 T
using image-guided localised spectroscopy by ISIS (image-
selected in vivo spectroscopy) (Ordidge et al;, 1986), with
adiabatic pulses, a recycle time of 3 s and a gradient strength
of 7.5 x 10-4 T cm-l. On average a volume of 0.8 cm3 was
selected using a two-turn 1 or 2 cm solenoid coil (depending
on tumour size and shape). Pre- and post-occlusion spectra
were obtained with an interleaved ISIS localisation acquired
in 320 scans (total) with the transmitter frequency set on
a-NTP in one spectrum (Figure 3a) and on 3-APP in the
other (see Figure 3b). Because the chemical shift difference
between 3-APP and cx-NTP was >30p.p.m. there was a
significant chemical shift artefact and the double interleaved
ISIS acquisition was used to minimise this problem (see
Maxwell et al., 1994, and Discussion). To obtain adequate
signal/noise for the 3-APP signal it was necessary to double
the dose (to 0.3ml of 128mgml1') 12-15ytmolg-' body
weight given by Gilles et al. (1994) which produced a peak
between 32 and 34 p.p.m. (relative to o-NTP). The mice
tolerated this increased dose very well and there were no
deaths that could be attributed to it.
For the chemical shift imaging (ID-CSI) experiment, 64
transients were acquired for each of 32 phase-encoding steps
over a 4 cm field of view. The acquisition time was 128 ms
with a repetition time of 2 s and 8 kHz spectral width.
Data processing
The MR spectra were analysed using VARPRO, a time
domain fitting routine (van der Veen, et al., 1988). Because
the chemical shift artefact causes more distortion to the
P-NTP peak than the y-NTP, the latter has been used to
calculate the NTP/Pi ratios. The contribution from free NDP
is considered negligible and likely to be in the micromolar
range (Stubbs et al., 1989).
pH measurements
pHi was measured from the difference in chemical shift
between the Pi resonance and that of x-NTP at -7.57 p.p.m.
according to Pritchard et al. (1983). The value for pH, was
measured from the chemical shift difference between 3-APP
and a-NTP. In the occlusion experiments, the reference signal
(a-NTP), disappeared after 30-40 min and in these cases the
chemical shift value obtained for the x-NTP peak before the
a-NTP signal disappeared was used for calculation of pH,
and pHe. For this analysis a standard curve was constructed
in vitro by setting up solutions at 19 pH intervals between pH
4.93 and 9.01 containing 0.154 M sodium chloride, 5 mM
potassium chloride, 30 mM Pi, 30 mM ATP, 30 mM PCr,
30 mM magnesium chloride and 30 mM 3-APP. 31p MR spec-
tra were collected under our standard conditions from the
solutions in a glass sphere, similar in shape to the tumours
we examined. The chemical shift was referenced to a-ATP.
In vivo experiments
Temperature was monitored throughout the experiments via
a rectal probe and maintained by a bath of circulating warm
water. During vascular occlusion mouse core temperatures
were maintained at preocclusion values (33-35°C) or allowed
to cool naturally to room temperature (22-24°C). During the
FAA experiments the core temperature was maintained at
about 31-33°C.
Statistical analyses
The results from the in vivo experiments were analysed using
the Student's t-test and are reported as mean ± s.e.m.
Freeze clamping
Two hours after vascular occlusion some of the tumours
were freeze clamped. Extracts of the tumours were assayed
for adenine nucleotides by high-performance liquid chroma-
tography (HPLC), lactate according to Bergmeyer (1974) and
Pi according to Lowry and Lopez (1946) as modified by
Chandra Rajan and Klein (1976).
Results
Occlusion Studies
The results in Figure 1 show the chemical shift dependence
on pH for 3-APP. The data were fitted to the Hender-
son-Hasselbalch equation to obtain an estimated pKa of 6.91
for 3-APP with a limiting acid chemical shift of 34.30 p.p.m.
and base chemical shift of 31.11 p.p.m. Using similar exper-
imental conditions, Gillies et al. (1994) reported a slightly
higher value (7.1) for the pKa of 3-APP. They also noted that
standard curves constructed at different temperatures or ionic
strengths did not significantly affect the values reported for
PKa3-App.
Preliminary experiments were performed to ascertain that
3-APP was present in the tumours. The CSI experiment
(Figure 2), which gives an overall view of where the MR
signal is coming from, demonstrates that the majority of the
3-APP signal is from the tumour along with signal from Pi
and the a-, P- and y-phosphates of NTP. The PCr signal
comes only from the muscle of the body wall and there
appears to be no 3-APP signal coming from this region. The
sensitivity of this experiment is insufficient to make any
statements about the homogeneity of the 3-APP in the
tumour.
The values for pHi of CaNT tumours in the absence and
presence of 3-APP were 7.1 ± 0.09 (n = 11) and 7.08 ± 0.06
(n = 8) respectively, indicating that the presence of 3-APP did
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Figure 1 pH dependence ofthe chemical shift of 3-APP. pKa3-APP
was calculated as 6.91 (see Materials and methods for details). It
should be noted that phosphonate resonances shift to lower
frequencies at higher pH, the opposite to phosphates, which shift
to higher frequencies at higher pH values (Prichard et al., 1983).Intra- and extracellular pH measured by 31p MRS
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Figure 2 A one-dimensional CSI contour plot indicating the location of the metabolites measured over the different anatomical
regions of the mouse. The spectrum at the top is of the metabolites summed over the whole region.
not affect pHi. When pHi and pH, were measured simult-
aneously in the CaNT tumours, the value for pH' was
6.7 ± 0.05 (n = 8) which is about 0.4 pH units more acid than
pHi and is significantly different from pHi (P<0.005). Spec-
tra obtained with an interleaved ISIS acquisition (see
Materials and methods for details) from one of the tumours
examined are shown in Figure 3a and b. The findings are
consistent with the results of Gillies et al. (1994) for RIF-1
tumours.
The plots in Figure 4, before and up to 128 min after
occlusion, demonstrated that both pHi and pII decreased
after occlusion. The values for pH; after occlusion decreased
on average by 0.51 and 0.68 pH units for the room
temperature and 33-35°C experiments respectively. On the
other hand, pH, decreased by less, 0.35 for the room
temperature and 0.41 for the 33-35°C experiments. Values
for pHpt measurements reported previously (Parkins et al.,
1994a) also showed decreases in pHpt after occlusion, but in
those experiments a relatively larger decrease (0.5 pH units)
was observed at 33-35°C when compared with room temper-
ature (0.2 pH units) after 120 min occlusion.
Although the ApH (i.e. the difference between pHi and
pHK) appeared smaller in both the tumours maintained at
room temperature and tumours maintained at 33-35°C after
occlusion, decreasing from 0.31 ± 0.13 to 0.17 ± 0.015 and
from 0.53 ± 0.04 to 0.28 ± 0.13 respectively, these differences
were not statistically significant.
Concomitant with the decrease in pHi and pH, after occl-
usion, there was a decrease in NTP/Pi ratio with time (Figure
5). Spectra from one of the tumours before and after occ-
lusion, with the temperature maintained at 33-35°C, are
shown in Figure 6. There are significant decreases in y-NTP/
Pi with time up to 48 min post-occlusion (Figure 5) at both
temperatures, after which no further changes were observed.
The rate at which the NTP/Pi ratio decreased at the higher
temperature was not significantly different from the NTP/Pi
ratio of the tumours maintained at room temperature.
Metabolites measured in extracts of CaNT tumours at the
end of the experiment (Table I) showed that there had been
significant breakdown of adenine nucleotides after occlusion
(P<0.01) although no significant differences were observed
between tumours maintained at room temperature and
tumours maintained at 35°C. This is in accordance with the
observations made by MRS (Figure 5) that no further
decreases in NTP/Pi were observed after 48 min of occlusion
when a plateau appears to have been reached.
FAA studies
pHi and pH, were also followed for 2 h after treatment of the
animals with FAA, an agent that reduces blood flow by
coagulopathy (Murray et al., 1989). The NTP/Pi ratios
(Figure 7) and pHi and pH, measurements obtained indicated
that there were two different responses to FAA. Nine mice
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Figure 3 pH, and pH, of CaNT murine tumour measured by 31P
MRS. 31P MR spectra were obtained with an interleaved ISIS
localisation acquired with the transmitter frequency set on a-NTP
in the upper spectrum (a) and on 3-APP in the lower spectrum
(b) 30 min after the mice were injected with 3-APP. pH, was
measured from the chemical shift difference between ac-NTP and
Pi in the upper spectrum. pH0 was measured from the chemical
shift difference between 3-APP in the lower spectrum and x-NTP
in the upper spectrum to correct for the chemical shift artefact
(for further details see text).
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Figure 4 (a) Time course of pHi (0) and pHe (0) measured
before and after vascular occlusion with mouse core temperature
maintained at room temperature (22-24°C). Symbols represent
mean ± s.e.m. (n = 3). (b) Time course of pH, (0) and p1i0 (0)
measured before and after vascular occlusion with mouse core
temperature maintained at 33-35°C. Symbols represent mean-
± s.e.m. (n = 3). *Indicates significant difference (P<0.05) from
values observed at 0 min.
were treated with FAA, five showed no significant decrease in
the NTP/P, ratio 2 h after treatment whereas in the other
four tumours the NTP/Pi ratio started to decrease after
68 min and was significantly different from the control values
after 100 min of treatment. In the group of four tumours, the
pH1 correspondingly decreased (but not significantly) from
7.08 0.02 to 6.85 ± 0.05 and the pH, from 6.66 ± 0.08 to
6.23 0.16 by the end of the experiment. In contrast, in the
non-responders, pHi (7.24 ± 0.1 at the beginning of the
experiment and 7.16 ± 0.05 at the end) was virtually
unchanged as was pH0 (6.75 ± 0.05 at the beginning and
6.59 ± 0.05 at the end).
The decreases in the responders were not significant but in
the same direction and of a similar magnitude to those found
for total vascular occlusion (see Figure 4). This is probably
because FAA takes a long time to exert its effect (relative
tumour perfusion -~- 21% of control after 200 mg kg-1; see
Hill et al., 1989). However it is not possible to look at later
times in these experiments because the 3-APP has to be given
before the FAA, when the vasculature is still patent. The
3-APP gradually disappears from the tumour with time leav-
ing no marker of extracellular space at the later times and
the signal/noise deteriorates.
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Figure 5 Time course of y-NTP/P, ratios measured before and
after vascular occlusion with mouse core temperature maintained
at either 22-24°C (0) or 33-35°C (0). (n = 3) for each point at
each temperature. Symbols represent mean ± s.e.m. *Indicates
significant difference (P<0.05) from values observed at 0 min.
Discussion
Direct non-invasive measurements of pHi in tumours have
changed the view that existed for many years after Warburg's
experiments of the 1920s, namely that tumours were 'acidic'
(for review see Griffiths, 1991). Now it is possible to make
direct, non-invasive (except for injecting the marker, 3-APP)
measurements of pH. However these measurements do
represent volume-average pH values and this may not be
ideal in tumours that are known to be histologically
heterogeneous. However, some strength lies in using volume
averages, especially since they are directly comparable with
subsequent metabolic assays done on freeze-clamped tumours
which also represent volume averages. One drawback of the
volume-average method is that pH. values obtained by 31P
MRS are likely to be different from pH0 values obtained by
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Table I Effect ofvascular occlusion for 2 h on adenine nucleotides [ATP]/[ADP][PJ]
and lactate in extracts of CaNT tumours
Total
adenine
nucleotides [ATP]/[ADP][Pi] Lactate
Treatment (pmolg-') M-1 (.molg')
Control (n = 3) 2.16 ± 0.14 1107 ± 268 7.8 ± 0.6
Occlusion (n = 5) 1.2 ± 0.08* 51 ± 8.2* 21 ± 2.3*
at 22-24°C
Occlusion (n = 7) 0.99 0.17* 80 31* 19 2.2*
at 33-35°C
*Significantly different from control value (P<0.05).
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Figure 6 Representative 31p spectra showing preocclusion (a)
and the decrease in '-NTP/P, with time 16-32 min (b) and
32-48 min (c) post occlusion. Mouse core temperature was main-
tained at (33-35°C).
microelectrodes since microelectrode measurements are inv-
asive and can only sample a few microenvironments within a
tumour. The values found in untreated tumours for pH, by
31p MRS were somewhat lower than those found by mic-
roelectrode studies in the same tumour type (although per-
formed on different batches at different times (see Parkins et
al., 1994a), and this may reflect differences between the tech-
niques. The wide range of pH (5.8-7.52) found in tumours
by microelectrode measurements (see Wike-Hooley et al.,
1984) suggests that they are sampling a mixture of compart-
ments (see also Vaupel et al., 1989) whereas the range of
pHAPP is very narrow (6.5-6.8) in untreated tumours (see
Gillies et al., 1994 and this paper).
In spite of these discrepancies both microelectrodes and
3-APP methods confirm that the extracellular compartment is
more acid than the intracellular compartment (see also
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Figure 7 Time course of y-NTP/P, ratios measured after treat-
ment with 200mgkg-' of FAA. (0) are the responders (n =4)
and (0) are non-responders (n = 5). The 0 min value was
obtained from control animals with no treatment (n = 3). Sym-
bols represent mean ± s.e.m. *Indicates significant difference
(P<0.05) from values observed at 36 min, the first post-FAA
treatment value obtained.
Vaupel et al., 1989; Griffiths, 1991; Stubbs et al., 1994).
Further studies, in which pHe will be measured on the same
tumour by both 31p MRS-3-APP and microelectrodes are
planned to begin shortly and we hope these studies will
resolve the differences between the two methods.
In this study, ISIS localisation of the tumours was chosen
to ensure that the intense PCr signal from the body wall did
not contribute to the tumour spectra (Howe et al.,. 1992).
However, because the chemical shift difference between
3-APP and a-NTP is > 30 p.p.m. there would be a significant
chemical shift artefact (Howe et al., 1992). The consequence
of this would be that the volumes from which the 3-APP and
the a-NTP signals were obtained would be displaced by
2 mm (in three dimensions). In a 0.8 cm3 volume of interest
(chosen for most of our experiments), the volumes from
which the signals arose would have overlapped by only 43%.
To ensure that the chemical shift artefact was minimised and
that a-NTP and 3-APP signals came from an identical
volume, the double interleaved ISIS acquisition (Maxwell et
al., 1994) was used for all ISIS experiments. It should be
noted that the chemical shift artefact is negligible when cal-
culating pHi because the chemical shift difference between Pi
and ax-NTP is < 10 p.p.m.
In theory, absolute concentrations can be obtained from
31p MRS since the area under the signals in the MR spect-
rum are directly proportional to the concentration of the
I
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metabolites. However, since ISIS localisation was used, the
results presented here have been expressed as peak ratios (i.e.
NTP/Pi) since absolute sensitivity depends on coil loading
and the relative position of the selected voxel to the coil. It
should be noted that this ratio (NTP/Pi) only approximates
the energy status of the tumour in real time. In order to
obtain information about the metabolic status of the tumour
that might approximate thermodynamic information, [ADP]
would have to be ascertained. While [ADP] cannot be deter-
mined directly from in vivo 31p MR spectra, total [ADP]
(free + bound) can be ascertained by freeze clamping and
making extracts of the tumour with subsequent assays of
ATP, ADP and Pi. Although this does not give true thermo-
dynamic information, it does give the direction, and some
indication of the magnitude of the changes observed.
An additional caveat is that the MR spectrum includes all
the nucleotide phosphates under the peaks which accounts
for the conventional label of NTP, although the major pro-
portion of this peak is ATP (Stubbs et al., 1989). However,
the extracts provide data on ATP since HPLC separates ATP
from other trinucleotides. The maintenance of adenine
nucleotides in tumours compared with control tissue (e.g.
liver or kidney) over relatively long periods of ischaemia is
supported by anaerobic glycolysis (Williamson et al., 1970;
Weber et al., 1971) and the expected large increase in lactate
and fall in [ATP]/[ADP][PJ] was observed in these tumours.
Lowering pHe in isolated cell experiments enhances cytot-
oxicity of certain anti-cancer drugs e.g. doxorubicin, mel-
phalan (for review see Wike-Hooley et al., 1984). Similarly
agents that cause vascular occlusion (e.g. FAA), subsequently
increase the cytotoxic effect of drugs (such as mitomycin C
and chlorambucil in vivo (Parkins et al., 1993, 1994b). Now
that it is possible to monitor pHi and pHe simultaneously, we
have investigated the effect of total vascular occlusion on pHi
and pHe at room temperature (22-24°C) and at 33-35°C.
The values for pHe of CaNT tumours were up to 0.4 pH
units more acid than pHi. This in itself would enable a drug
which was a weak acid (eg. chlorambucil), to partition more
favourably into the more alkaline intracellular compartment.
However the energy of ATP hydrolysis [ATP]/[ADP][Pj]
required to maintain the proton gradient is decreased in
tumours compared with normal tissues (Stubbs et al., 1994)
and after vascular occlusion, this ratio ([ADT]/[ADP][PJ-)
decreases even further. This combined with the inability of
the tumour to remove products of ischaemia such as lactate,
contributes to the collapse of ApH, caused largely by a
decrease in pHi. In the tumours which respond to FAA there
is also a decrease, to about the same extent, in both pHi and
pHe.
These results clearly indicate that tumour regions subjected
to ischaemia do not display an enhanced differential between
pHi and pH,. Thus, for chemotherapeutic drugs with weak
acid functions such as chlorambucil, whose increased activity
at reduced pH, in vitro is primarily due to increased uptake
as a result of the larger transmembrane ApH, no enhanced
toxicity in such regions should be expected. However, as
mentioned earlier, the tumour cytotoxicity of chlorambucil is
enhanced if combined with agents which induce tumour
ischaemia such as FAA (Parkins et al., 1994b). Two possible
explanations for this result are: (i) if chlorambucil is given
before an agent which induces tumour ischaemia (i.e. when
the vasculature is still patent), then the pharmacokinetics of
the agent could be altered by 'trapping' of the drug in the
tumour; (ii) it is known that with FAA a small percentage of
vessels remain functional and these supply the tumour cells
which elicit tumour regrowth following FAA treatment
alone. Thus if the majority of the tumour is made ischaemic,
acidic metabolites could diffuse and reduce the pH, in such
areas, although, because they still have an adequate blood
supply, the cells could still maintain their pHi. In this
scenario chlorambucil would have increased toxicity against
this remaining subpopulation.
The data obtained show that there are two different res-
ponses to FAA - a significant decrease in NTP/Pi ratio and
a non-significant decrease in pHi or pHe for responders com-
pared to a non-significant decrease in NTP/Pi ratio and no
change in pHi or pH, for non-responders after FAA treat-
ment. However, this interpretation should be taken with
caution because it is possible that the results do not indicate
two completely separate responses, but rather the two ext-
remes of the response within a continuum.
Simultaneous and non-invasive monitoring of volume
average pHi and pHe of solid tumours in vivo, demonstrates
that pHi is more alkaline than pHe and that both decrease
after vascular occlusion, or in response to FAA, concomitant
with a decrease in the [ATP]/[ADP][PJ.
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